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SUMMARY 
Rheumatoid arthritis is a painful and crippling systemic disease for which there is no 
cure. Ayurveda is becoming popular with more and more people accepting its holistic 
approach to healing. The anti-arthritic activity of an ayurvedic formulation Yogaraja 
gulgulu was studied in rats. The formulation was then subjected for preliminary 
phytochemical studies and pharmacological investigation. The anti-arthritic activity was 
carried out by Fruend’s adjuant arthritis model. The ayurvedic formulation has exhibited 
significant anti-arthritic activity. The phytoconstituents screening reveals the presence of 
required component for anti-arthritic activity. The present study concludes that the 
yogaraja gulgulu can be used as anti-arthritic drug.  
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1. Introduction 
Ayurveda is becoming popular with 
more and more people accepting its holistic 
approach to healing. Ayurveda is a science of 
life, it is a science of which comprises how to 
lead to a long healthy life. According to 
ayurveda health is the maintenance of the 
balance of the forces in the body. When this 
balance is upset the body becomes diseased. 
Ayurveda treats men as whole. This is 
combination of body, mind and soul. It is one 
of the oldest scientific medical systems in the 
world with long record of clinical experience. 
It divided in to eight branches; its aim is to 
achieve positive health for individual, 
protection of masses and ultimate liberation. 
Ayurveda is effective in the treatment of 
refractory skin disease, classified as kushta, 
Psoriasis for instance is a difficult conditions 
to treat. Eczema, dermatophyte infection of 
ringworm1 for fungal infections, pilriaisis 
and other gynecological disorders can be 
effectively treated by ayurveda practice. 
Besides, Ayurveda preparations are safe and 
do not have any side effects. Dasmula tila 
ultarabastic is found to be effective in 
treating in the spermatozoa agglutination 
from 60%-20% has been observed. 
Menopausal symptoms can be treated 
without hormone replacement therapy with 
ayurveda practice. In to traditional systems 
of medicine many polyherbal formulations 
are being prescribed for inflammatory 
conditions.2 Although these preparations 
have been claimed to have anti-inflammatory 
activity and some of the individual plant 
ingredients of the formulations have been 
shown to have anti-inflammatory activity3 
Rheumatoid arthritis (RA) is a chronic 
autoimmune disease in which there is 
inflammation of joints, sinovial proliferation 
and destruction of articular cartilage.4  
Although a number of drugs such as 
steroids5 and non steroids6 being used in the 
treatment of RA have been developed in the 
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past few decades, there is still and urgent 
need for more effective drugs with lower 
side effects.7  With brief literature survey, it 
found that there were no publications or 
studies on the formulation which we have 
used for the study. The aim and objective of 
the current study was to confirm 
phytochemical constituents present in the 
formulations and to investigate the anti-
arthritic activity of the formulation 
comparing with Indomethacine as standard. 
 
2. Materials and Methodology 
Ayurvedic Formulation 
Yogaraja Gulgulu was purchased from 
local ayurveda medical shops, Indomethacin 
sample gifted by (CIPLA Limited, Mumbai) 
and other solvents Acetone, Ethanol, 
Methanol, Benzene, Chloroform were 
supplied by (S.D fine chemicals, Mumbai), all 
other chemicals and solvents were  analytical 
grade.  
Animals 
Wistar rats (200-250 g) were used. The 
animals were housed under standard 
conditions of temperature (23±1°C), relative 
humidity (55±10%), 12 hr/12 hr light/dark 
cycles and fed with standard pellet diet 
(Amrut, Pranav Agro Industries Ltd., Sangli, 
India) and tap water ad libitum. 
Formulation of Pills of Yogaraja Gulgulu 
The Yogaraja gulgulu is available as pills 
in the market and the method of preparation 
described as follows, kasayam was prepared 
by using 4 gm of powdered amirthavalli, 
then the gulgulu was fried with ghee and 
then grinded well. The grinded gulgulu was 
added to the Kasyam along with remaining 
ingredients to it with continuous trituration 
to make pills. The pills were administered 1-
2 pills once or twice a day. 
 
Preliminary Phytochemical Screening 
The ayurvedic formulation Yogaraja 
gulgulu was screened for the presence of 
various phytoconstituents8,9 for the presence 
or absence of various primary or secondary 
metabolites employing standard screening 
test Conventional protocol for detecting the 
presence of glycosides, saponins, flavonoids, 
and tannins etc.was used.  
Solubility Studies 
To understand the solubility of the 
Ayurvedic formulation Yogaraja gulgulu, the 
solubility studies were carried out by using 
various solvents, in this method; one part of 
the formulation was placed in narrow 
mouthed screw cap container and the each 
solvent was added in respective container 
with continuous shaking using thermostatic 
shaker for 24 hours and found the solubility 
of the formulation.   
Freund’s Adjuvant Induced Arthritis  
Rheumatoid arthritis is a painful and 
crippling systemic disease for which there is 
no cure. The best experimental model for 
studying rheumatoid arthritis in humans is 
the adjuvant induced arthritis in rats.10 The 
anti-arthritic activity was carried out with 
modified procedure.11,12 Rats were divided 
into four groups of 6 animals each. Adjuvant 
arthritis was induced by subcutaneous 
injection of complete Freund’s adjuvant 
(CFA - 0.1mL of 0.5% w/v suspension of 
heat killed Mycobacterium tuberculosis cells in 
liquid paraffin) into the plantar tissue of the 
right hind paw of each rat. Rats in this group 
were known as inflammed control group I. 
Group II received the doses of the test drugs 
100 mg/kg bw and  Group III received the 
standard drug (2.5 mg/kg bw). Group IV 
served as the non-inflammed control group 
consisted of rats injected with 0.1 mL of 
liquid paraffin. The test groups consisted of 
complete Freund’s adjuvant (CFA)-injected 
rats challenged with doses of the test drug 
administered orally 2 h before induction of 
arthritis. The drug administrations were 
continued daily at the same time of the day 
for 9 more days. Development of adjuvant 
induced swelling in the paws of both the 
injected and non-injected paws of each rat 
were monitored daily as the percentage 
increase in paw volume. The percentage 
inhibition of paw volume compared with 
that of the inflammed control was taken as 
anti-arthritic activity.  
Percentage inhibition inflammation = (A - B) 
/ A x 100 
Where A represents the paw volume of 
control group and B is the paw volume of the 
test group. The dosage details of the arthritis 
experiment are presented in Table 4. 
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Table:1 Composition, biological source, parts used and family of  Yogaraja gulgulu 
 
Table.2: Qualitative analysis of the phytochemicals of Ayurvedic formulation Yogaraja Gulgulu, ‘+’ Indicates 
Presence of compound, ‘-‘Indicates absence of compound 
S.No. Phytoconstituents Ayurvedic 
formulation 
1 Alkaloids + 
2 Tannins + 
3 Flavonoids + 
4 Phytosterols - 
5 Sponins + 
6 Proteins & Amino acids - 
7 Phenolic compound - 
8 Carbohydrates + 
9 Glycosides - 
10 Fixed oils &fats + 
11 Gums & Mucilage - 
12 Lignin + 
13 Terpenes + 
S.no. Ingredients Biological source Family Part used 
1 Amurutavalli Tinospora cordifola Menispermaceae Stem 
2 Khurassani Hyoscyamus niger  Solanaceae Leaves & seeds 
3 Kotuveli Plumbago indica Plumbaginaceae Roots 
4 Aratha Alpinia galanga Gingiberaceae Rhizomes 
5 Nerinci Tribulus terrestris Zygophyllaceae Whole plant 
6 Kottamalli Coriandrum staivum Apiaceae Leave & Fruits 
7 Katukka Teminalia chebula Combretaceae Fruits 
8 Nellikka Phyllanthus embalica Emphorbiaceae Bark, leaves & fruits 
9 Tannikka Terminalia bellica Combretaceae Bark & fruits 
10 Muttanga Cyperus rotundus Cyperaceae Tubers 
11 Chukku Gigiber officinale Gingiberaceae Rhizomes 
12 Kurumilagu Piper nigrum Piperaceae Fruits 
13 Elavangam Cinnamomum verum, 
C. Zeylanicum 
Lauraceae Bark & Oil 
14 Ramacham-Vettiver Vetiveria zizanioides Poaceae Roots 
15 Talispatri Abies spectabilis Pinaceae Leaves 
16 Nagappu Mesua Nagassarium Clusiaceae Flower & Oil 
17 Kaccoram Kanpferia galangal Gingiberaceae Rhizome, root stock & 
leaves 
18 Nagandanti Baliospermum 
montanum 
Euphorbiaceae Roots, leaves & seeds 
19 Pakku Areca catchu Arecaceae Roots, leaves & fruits 
20 Amukkuram Withania somnifera Solanaceae Roots & leaves 
21 Sathavari Asparagus racemosus Liliaceae Tuberous root 
22 Gulgulu Commiphora mukol Burseraceae Resinous gum 
23 Tippili Piper longum Piperaceae Roots,& Spikes 
24 Karinjeeragam Nigella sativa Ranunculaceae Seeds 
25 Vidangah Embelia ribes Myrsinaceae Roots, leaves & fruits 
26 Ayamodakam Trachyspermum Apiaceae Fruits  
27 Jeerakam Cuminum cyminum Apiaceae Fruits 
28 Devadaru Cedrus deodara Pinaceae Leaves &oil 
29 Kattumilagu Toddalia Asiatica Rutaceae Roots, leaves, fruits & 
flower 
30 Elam Elettaria cardamomum Gingiberaceae Seeds & oil 
31 Kottam Saussurea lappa Asteraceae Roots 
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Table: 3 Solubility studies of formulation yogaraja gulgulu in various solvents. 
‘S’ Indicates soluble ‘NS’ indicates not-soluble or insoluble 
S. No. Solvents Solubility 
1 Acetone NS 
2 Benzene NS 
3 Chloroform NS 
4 Carbon tetra chloride NS 
5 Ethanol S 
6 Methanol NS 
7 Petroleum ether NS 
8 Propylene glycol S 
9 Arachis oil S 
10 Castor oil NS 
11 Sesame oil NS 
12 Coconut oil NS 
13 Hot water S 
 
Table-4 Anti-arthritic activity of Ayurvedic formulation Yogaraja Gulgulu against Freund’s adjuvant induced 
arthritis 
 
Group 
 
Treatment 
% increase in paw volume 
Post insult time of assay in days 
1 3 5 7 9 
Group-I Control  
(Inflammed) 
72.7±1.2 81.3±1.5 95.9±1.2 97.6±1.1 100.1±1.3 
Group-II Test drug 
(100mg / kg) 
50.7±1.7 
(30.2) 
50.1±1.9 
(38.3) 
57.7±2.1 
(39.8) 
53.3±1.2 
(45.3) 
48.2±1.9 
(51.8) 
Group-III Indomethacin 
(2.5mg/kg ) 
48.2±1.3 
(33.7) 
46.8±2.4 
(42.4) 
45.2±2.1 
(52.8) 
44.3±2.6 
(54.6) 
34.3±1.5 
(65.7) 
Group-IV Control (non-
inflammed) 
15.6±2.2 23.5±2.1 29.3±1.8 46.4±2.4 26.7±1.8 
Each value is the mean ±SEM of 6 rats. The number in the parentheses indicates the percentage inhibition of 
the inflammation 
 
3. Results 
Composition, its biological sources, parts 
used and the family of the evaluated 
formulation of Yogaraja gulgulu given in 
Table-1. The poly herbal formulation of 
yogaraja gulgulu which contains more 
number of medicinal herbs, this may be the 
reason the ayurvedic formulation is used for 
multiple therapeutic conditions such as anti-
inflammatory, skin diseases, anthelmintic, 
bronchitis, scabies, nervine stimulant, 
rheumatoid arthritis, analgesic, antiseptic, 
flatulence, stomachi, antispasmodic, 
antibacterial etc.,  The preliminary 
phytoconstituents present in the formulation 
tabulated in Table-2. Which reveals that the 
presence of alkaloids, terpines, 
carbohydrates, flavounoids, saponins, 
tannins, fixed oils and fats.    The solubility of 
the Ayurvedic formulation were studied in 
various solvents and indicated in table-3. it 
was freely soluble in organic solvents like 
ethanol and propylene glycol and in arachis 
oil, and in hot water also. But, it was not 
soluble in other solvents mentioned in table-
3. The anti-arthritic effect of the yogaraja 
gulgulu started on day 1, which continued 
till day 9 when compared with that of the 
control (Table 4). In the case of standard drug 
maximum inhibition was observed on day 1 
itself. Whereas in the case of 100 mg/kg 
body weight dose of the test drug maximum 
inhibitions were noticed on day 5. In all the 
two cases the inhibition started decreasing 
after day 5.(Table 4). 
4. Discussion 
In adjuvant induced arthritis model, rats 
develop a chronic swelling in multiple joints 
with influence of inflammatory cells, erosion 
of joint cartilage and bone destruction and 
remodeling. These inflammatory changes 
ultimately result in the complete destruction 
of joint integrity and function in the affected 
A.Puratchikody et al./J Phytol 3/3 (2011) 31-36 
 
animals.13 Chronic inflammation involves the 
release of number of mediators like cytokines 
(IL-Iβand TNF-α), GM-CSF, interferons and 
PGDF. These mediators are responsible for 
the pain, destruction of bone and cartilage 
that can lead to severe disability.14  Several 
phytoconstituents like flavonoids, saponins 
and glycosides are known to promote anti-
arthritic activity due to their antioxidant and 
antimicrobial activities15 the yogaraja 
gulgulu which contains number of herbs in it 
having the various phytocontituents may 
acts on arthritic pain. With help of above 
data we may conclude that the ayurvedic 
formulation of Yogaraja gulgulu can be used 
to treat arthritic pain or rheumatoid arthritis. 
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